Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Immortalized Human Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Immortalized Human Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Immortalized Human Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-24

Pages: 108 Pages

Report ld: 6271408

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global Immortalized Human Cells market size was US$ 1577 million in 2025 and is forecast to reach a readjusted size of US$ 3407 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.

The global volume of technical services related to immortalized human cells reached approximately 3.72 million projects in 2024, with an average customer price of $403.15 per project. Immortalized human cells are human cell lines with unlimited proliferative capacity obtained through genetic engineering techniques. Related technical services include cell line establishment, gene editing, functional validation, drug screening, and customized culture. These services provide crucial technology platforms and solutions for drug development, disease modeling, and biomedical research, significantly enhancing research efficiency and reliability.

Immortalized Human Cells Market Size(US$)

M= millions and B=billions

QYRLogo
The technical service market for immortalized human cells is currently in a critical phase of rapid professionalization and standardization. The market's current state is characterized by growing demand for regulatory-compliant standardized cell line establishment, complex gene editing, and high-quality functional validation services, driven by the needs of precision medicine and personalized therapies. Professional CRO companies and large biotechnology firms dominate the market by establishing standardized technology platforms and quality systems. The development trend is clearly directed towards higher throughput and more precise technical services, including the integration of innovative services such as automated screening platforms, multi-omics analysis integration, and AI-assisted cell phenotype analysis. The prevailing market view is that future competition will extend beyond basic technical services to focus more on the capability to provide integrated solutions, data quality and depth of analytical value, and the completeness of technical systems meeting stringent regulatory requirements. Meanwhile, balancing service standardization with personalized needs will become a significant challenge for enterprises.

The global Immortalized Human Cells market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
By Company: 
    Ispecimen
    ABO Bio
    AnaBios
    Biomedica Cro
    Bioivt
    Iprocess
    Crown Bioscience
    Biomex
    PrecisionMed
    Cureline
    DX Biosamples
    Audubon
    Precision for Medicine
    Discovery Life Sciences
    ProteoGenex
    CGT Global

Segment by Type
    Ready-to-use
    Customized

Segment by Application
    Medical Research
    Vaccine Development
    Gene Therapy
    Other

By Region 
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
    North America
    Europe
    China
    Japan

(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Immortalized Human Cells market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets 
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities 
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Immortalized Human Cells value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market by Type
        1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
        1.2.2 Ready-to-use
        1.2.3 Customized
    1.3 Market by Application
        1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
        1.3.2 Medical Research
        1.3.3 Vaccine Development
        1.3.4 Gene Therapy
        1.3.5 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Immortalized Human Cells Market Perspective (2021-2032)
    2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
    2.3 Global Immortalized Human Cells Market Share by Revenue, by Region (2021-2026)
    2.4 Global Immortalized Human Cells Revenue Forecast by Region (2027-2032)
    2.5 Major Regions and Emerging Markets Analysis
        2.5.1 North America Immortalized Human Cells Market Size and Prospective (2021-2032)
        2.5.2 Europe Immortalized Human Cells Market Size and Prospective (2021-2032)
        2.5.3 China Immortalized Human Cells Market Size and Prospective (2021-2032)
        2.5.4 Japan Immortalized Human Cells Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
    3.1 Global Immortalized Human Cells Historical Market Size by Type (2021-2026)
    3.2 Global Immortalized Human Cells Forecasted Market Size by Type (2027-2032)
    3.3 Representative Players for Different Types of Immortalized Human Cells
4 Breakdown Data by Application
    4.1 Global Immortalized Human Cells Historical Market Size by Application (2021-2026)
    4.2 Global Immortalized Human Cells Forecasted Market Size by Application (2027-2032)
    4.3 New Sources of Growth in Immortalized Human Cells Applications
5 Competitive Landscape by Players
    5.1 Global Top Players by Revenue
        5.1.1 Global Top Immortalized Human Cells Players by Revenue (2021-2026)
        5.1.2 Global Immortalized Human Cells Market Share by Revenue, by Players (2021-2026)
    5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    5.3 Players Covered: Ranking by Immortalized Human Cells Revenue
    5.4 Global Immortalized Human Cells Market Concentration Analysis
        5.4.1 Global Immortalized Human Cells Market Concentration Ratio (CR5 and HHI)
        5.4.2 Global Top 10 and Top 5 Companies by Immortalized Human Cells Revenue in 2025
    5.5 Global Key Players of Immortalized Human Cells Head Offices and Areas Served
    5.6 Global Key Players of Immortalized Human Cells, Product and Application
    5.7 Global Key Players of Immortalized Human Cells, Date of Entry into This Industry
    5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Immortalized Human Cells Revenue by Company (2021-2026)
        6.1.2 North America Market Size by Type
            6.1.2.1 North America Immortalized Human Cells Market Size by Type (2021-2026)
            6.1.2.2 North America Immortalized Human Cells Market Share by Type (2021-2026)
        6.1.3 North America Market Size by Application
            6.1.3.1 North America Immortalized Human Cells Market Size by Application (2021-2026)
            6.1.3.2 North America Immortalized Human Cells Market Share by Application (2021-2026)
        6.1.4 North America Immortalized Human Cells Major Customers
        6.1.5 North America Market Trends and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Immortalized Human Cells Revenue by Company (2021-2026)
        6.2.2 Europe Market Size by Type
            6.2.2.1 Europe Immortalized Human Cells Market Size by Type (2021-2026)
            6.2.2.2 Europe Immortalized Human Cells Market Share by Type (2021-2026)
        6.2.3 Europe Market Size by Application
            6.2.3.1 Europe Immortalized Human Cells Market Size by Application (2021-2026)
            6.2.3.2 Europe Immortalized Human Cells Market Share by Application (2021-2026)
        6.2.4 Europe Immortalized Human Cells Major Customers
        6.2.5 Europe Market Trends and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Immortalized Human Cells Revenue by Company (2021-2026)
        6.3.2 China Market Size by Type
            6.3.2.1 China Immortalized Human Cells Market Size by Type (2021-2026)
            6.3.2.2 China Immortalized Human Cells Market Share by Type (2021-2026)
        6.3.3 China Market Size by Application
            6.3.3.1 China Immortalized Human Cells Market Size by Application (2021-2026)
            6.3.3.2 China Immortalized Human Cells Market Share by Application (2021-2026)
        6.3.4 China Immortalized Human Cells Major Customers
        6.3.5 China Market Trends and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Immortalized Human Cells Revenue by Company (2021-2026)
        6.4.2 Japan Market Size by Type
            6.4.2.1 Japan Immortalized Human Cells Market Size by Type (2021-2026)
            6.4.2.2 Japan Immortalized Human Cells Market Share by Type (2021-2026)
        6.4.3 Japan Market Size by Application
            6.4.3.1 Japan Immortalized Human Cells Market Size by Application (2021-2026)
            6.4.3.2 Japan Immortalized Human Cells Market Share by Application (2021-2026)
        6.4.4 Japan Immortalized Human Cells Major Customers
        6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
    7.1 Ispecimen
        7.1.1 Ispecimen Company Details
        7.1.2 Ispecimen Business Overview
        7.1.3 Ispecimen Immortalized Human Cells Introduction
        7.1.4 Ispecimen Revenue in Immortalized Human Cells Business (2021-2026)
        7.1.5 Ispecimen Recent Development
    7.2 ABO Bio
        7.2.1 ABO Bio Company Details
        7.2.2 ABO Bio Business Overview
        7.2.3 ABO Bio Immortalized Human Cells Introduction
        7.2.4 ABO Bio Revenue in Immortalized Human Cells Business (2021-2026)
        7.2.5 ABO Bio Recent Development
    7.3 AnaBios
        7.3.1 AnaBios Company Details
        7.3.2 AnaBios Business Overview
        7.3.3 AnaBios Immortalized Human Cells Introduction
        7.3.4 AnaBios Revenue in Immortalized Human Cells Business (2021-2026)
        7.3.5 AnaBios Recent Development
    7.4 Biomedica Cro
        7.4.1 Biomedica Cro Company Details
        7.4.2 Biomedica Cro Business Overview
        7.4.3 Biomedica Cro Immortalized Human Cells Introduction
        7.4.4 Biomedica Cro Revenue in Immortalized Human Cells Business (2021-2026)
        7.4.5 Biomedica Cro Recent Development
    7.5 Bioivt
        7.5.1 Bioivt Company Details
        7.5.2 Bioivt Business Overview
        7.5.3 Bioivt Immortalized Human Cells Introduction
        7.5.4 Bioivt Revenue in Immortalized Human Cells Business (2021-2026)
        7.5.5 Bioivt Recent Development
    7.6 Iprocess
        7.6.1 Iprocess Company Details
        7.6.2 Iprocess Business Overview
        7.6.3 Iprocess Immortalized Human Cells Introduction
        7.6.4 Iprocess Revenue in Immortalized Human Cells Business (2021-2026)
        7.6.5 Iprocess Recent Development
    7.7 Crown Bioscience
        7.7.1 Crown Bioscience Company Details
        7.7.2 Crown Bioscience Business Overview
        7.7.3 Crown Bioscience Immortalized Human Cells Introduction
        7.7.4 Crown Bioscience Revenue in Immortalized Human Cells Business (2021-2026)
        7.7.5 Crown Bioscience Recent Development
    7.8 Biomex
        7.8.1 Biomex Company Details
        7.8.2 Biomex Business Overview
        7.8.3 Biomex Immortalized Human Cells Introduction
        7.8.4 Biomex Revenue in Immortalized Human Cells Business (2021-2026)
        7.8.5 Biomex Recent Development
    7.9 PrecisionMed
        7.9.1 PrecisionMed Company Details
        7.9.2 PrecisionMed Business Overview
        7.9.3 PrecisionMed Immortalized Human Cells Introduction
        7.9.4 PrecisionMed Revenue in Immortalized Human Cells Business (2021-2026)
        7.9.5 PrecisionMed Recent Development
    7.10 Cureline
        7.10.1 Cureline Company Details
        7.10.2 Cureline Business Overview
        7.10.3 Cureline Immortalized Human Cells Introduction
        7.10.4 Cureline Revenue in Immortalized Human Cells Business (2021-2026)
        7.10.5 Cureline Recent Development
    7.11 DX Biosamples
        7.11.1 DX Biosamples Company Details
        7.11.2 DX Biosamples Business Overview
        7.11.3 DX Biosamples Immortalized Human Cells Introduction
        7.11.4 DX Biosamples Revenue in Immortalized Human Cells Business (2021-2026)
        7.11.5 DX Biosamples Recent Development
    7.12 Audubon
        7.12.1 Audubon Company Details
        7.12.2 Audubon Business Overview
        7.12.3 Audubon Immortalized Human Cells Introduction
        7.12.4 Audubon Revenue in Immortalized Human Cells Business (2021-2026)
        7.12.5 Audubon Recent Development
    7.13 Precision for Medicine
        7.13.1 Precision for Medicine Company Details
        7.13.2 Precision for Medicine Business Overview
        7.13.3 Precision for Medicine Immortalized Human Cells Introduction
        7.13.4 Precision for Medicine Revenue in Immortalized Human Cells Business (2021-2026)
        7.13.5 Precision for Medicine Recent Development
    7.14 Discovery Life Sciences
        7.14.1 Discovery Life Sciences Company Details
        7.14.2 Discovery Life Sciences Business Overview
        7.14.3 Discovery Life Sciences Immortalized Human Cells Introduction
        7.14.4 Discovery Life Sciences Revenue in Immortalized Human Cells Business (2021-2026)
        7.14.5 Discovery Life Sciences Recent Development
    7.15 ProteoGenex
        7.15.1 ProteoGenex Company Details
        7.15.2 ProteoGenex Business Overview
        7.15.3 ProteoGenex Immortalized Human Cells Introduction
        7.15.4 ProteoGenex Revenue in Immortalized Human Cells Business (2021-2026)
        7.15.5 ProteoGenex Recent Development
    7.16 CGT Global
        7.16.1 CGT Global Company Details
        7.16.2 CGT Global Business Overview
        7.16.3 CGT Global Immortalized Human Cells Introduction
        7.16.4 CGT Global Revenue in Immortalized Human Cells Business (2021-2026)
        7.16.5 CGT Global Recent Development
8 Immortalized Human Cells Market Dynamics
    8.1 Immortalized Human Cells Industry Trends
    8.2 Immortalized Human Cells Market Drivers
    8.3 Immortalized Human Cells Market Challenges
    8.4 Immortalized Human Cells Market Restraints
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Immortalized Human Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Global Immortalized Human Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 3. Global Market Immortalized Human Cells Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
 Table 4. Global Immortalized Human Cells Revenue (US$ Million) Market Share by Region (2021-2026)
 Table 5. Global Immortalized Human Cells Revenue Share by Region (2021-2026)
 Table 6. Global Immortalized Human Cells Revenue (US$ Million) Forecast by Region (2027-2032)
 Table 7. Global Immortalized Human Cells Revenue Share Forecast by Region (2027-2032)
 Table 8. Global Immortalized Human Cells Market Size by Type (2021-2026) & (US$ Million)
 Table 9. Global Immortalized Human Cells Market Share by Revenue, by Type (2021-2026)
 Table 10. Global Immortalized Human Cells Forecasted Market Size by Type (2027-2032) & (US$ Million)
 Table 11. Global Immortalized Human Cells Market Share by Revenue, by Type (2027-2032)
 Table 12. Representative Players of Each Type
 Table 13. Global Immortalized Human Cells Market Size by Application (2021-2026) & (US$ Million)
 Table 14. Global Immortalized Human Cells Market Share by Revenue, by Application (2021-2026)
 Table 15. Global Immortalized Human Cells Forecasted Market Size by Application (2027-2032) & (US$ Million)
 Table 16. Global Immortalized Human Cells Market Share by Revenue, by Application (2027-2032)
 Table 17. New Sources of Growth in Immortalized Human Cells Applications
 Table 18. Global Immortalized Human Cells Revenue by Players (2021-2026) & (US$ Million)
 Table 19. Global Immortalized Human Cells Market Share by Players (2021-2026)
 Table 20. Global Top Immortalized Human Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immortalized Human Cells as of 2025)
 Table 21. Ranking of Global Top Immortalized Human Cells Companies by Revenue (US$ Million) in 2025
 Table 22. Global 5 Largest Players Market Share by Immortalized Human Cells Revenue (CR5 and HHI) & (2021-2026)
 Table 23. Global Key Players of Immortalized Human Cells, Headquarters and Area Served
 Table 24. Global Key Players of Immortalized Human Cells, Product and Application
 Table 25. Global Key Players of Immortalized Human Cells, Date of Entry into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Immortalized Human Cells Revenue by Company (2021-2026) & (US$ Million)
 Table 28. North America Immortalized Human Cells Market Share by Revenue, by Company (2021-2026)
 Table 29. North America Immortalized Human Cells Market Size by Type (2021-2026) & (US$ Million)
 Table 30. North America Immortalized Human Cells Market Size by Application (2021-2026) & (US$ Million)
 Table 31. Europe Immortalized Human Cells Revenue by Company (2021-2026) & (US$ Million)
 Table 32. Europe Immortalized Human Cells Market Share by Revenue, by Company (2021-2026)
 Table 33. Europe Immortalized Human Cells Market Size by Type (2021-2026) & (US$ Million)
 Table 34. Europe Immortalized Human Cells Market Size by Application (2021-2026) & (US$ Million)
 Table 35. China Immortalized Human Cells Revenue by Company (2021-2026) & (US$ Million)
 Table 36. China Immortalized Human Cells Market Share by Revenue, by Company (2021-2026)
 Table 37. China Immortalized Human Cells Market Size by Type (2021-2026) & (US$ Million)
 Table 38. China Immortalized Human Cells Market Size by Application (2021-2026) & (US$ Million)
 Table 39. Japan Immortalized Human Cells Revenue by Company (2021-2026) & (US$ Million)
 Table 40. Japan Immortalized Human Cells Market Share by Revenue, by Company (2021-2026)
 Table 41. Japan Immortalized Human Cells Market Size by Type (2021-2026) & (US$ Million)
 Table 42. Japan Immortalized Human Cells Market Size by Application (2021-2026) & (US$ Million)
 Table 43. Ispecimen Company Details
 Table 44. Ispecimen Business Overview
 Table 45. Ispecimen Immortalized Human Cells Product
 Table 46. Ispecimen Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 47. Ispecimen Recent Development
 Table 48. ABO Bio Company Details
 Table 49. ABO Bio Business Overview
 Table 50. ABO Bio Immortalized Human Cells Product
 Table 51. ABO Bio Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 52. ABO Bio Recent Development
 Table 53. AnaBios Company Details
 Table 54. AnaBios Business Overview
 Table 55. AnaBios Immortalized Human Cells Product
 Table 56. AnaBios Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 57. AnaBios Recent Development
 Table 58. Biomedica Cro Company Details
 Table 59. Biomedica Cro Business Overview
 Table 60. Biomedica Cro Immortalized Human Cells Product
 Table 61. Biomedica Cro Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 62. Biomedica Cro Recent Development
 Table 63. Bioivt Company Details
 Table 64. Bioivt Business Overview
 Table 65. Bioivt Immortalized Human Cells Product
 Table 66. Bioivt Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 67. Bioivt Recent Development
 Table 68. Iprocess Company Details
 Table 69. Iprocess Business Overview
 Table 70. Iprocess Immortalized Human Cells Product
 Table 71. Iprocess Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 72. Iprocess Recent Development
 Table 73. Crown Bioscience Company Details
 Table 74. Crown Bioscience Business Overview
 Table 75. Crown Bioscience Immortalized Human Cells Product
 Table 76. Crown Bioscience Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 77. Crown Bioscience Recent Development
 Table 78. Biomex Company Details
 Table 79. Biomex Business Overview
 Table 80. Biomex Immortalized Human Cells Product
 Table 81. Biomex Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 82. Biomex Recent Development
 Table 83. PrecisionMed Company Details
 Table 84. PrecisionMed Business Overview
 Table 85. PrecisionMed Immortalized Human Cells Product
 Table 86. PrecisionMed Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 87. PrecisionMed Recent Development
 Table 88. Cureline Company Details
 Table 89. Cureline Business Overview
 Table 90. Cureline Immortalized Human Cells Product
 Table 91. Cureline Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 92. Cureline Recent Development
 Table 93. DX Biosamples Company Details
 Table 94. DX Biosamples Business Overview
 Table 95. DX Biosamples Immortalized Human Cells Product
 Table 96. DX Biosamples Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 97. DX Biosamples Recent Development
 Table 98. Audubon Company Details
 Table 99. Audubon Business Overview
 Table 100. Audubon Immortalized Human Cells Product
 Table 101. Audubon Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 102. Audubon Recent Development
 Table 103. Precision for Medicine Company Details
 Table 104. Precision for Medicine Business Overview
 Table 105. Precision for Medicine Immortalized Human Cells Product
 Table 106. Precision for Medicine Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 107. Precision for Medicine Recent Development
 Table 108. Discovery Life Sciences Company Details
 Table 109. Discovery Life Sciences Business Overview
 Table 110. Discovery Life Sciences Immortalized Human Cells Product
 Table 111. Discovery Life Sciences Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 112. Discovery Life Sciences Recent Development
 Table 113. ProteoGenex Company Details
 Table 114. ProteoGenex Business Overview
 Table 115. ProteoGenex Immortalized Human Cells Product
 Table 116. ProteoGenex Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 117. ProteoGenex Recent Development
 Table 118. CGT Global Company Details
 Table 119. CGT Global Business Overview
 Table 120. CGT Global Immortalized Human Cells Product
 Table 121. CGT Global Revenue in Immortalized Human Cells Business (2021-2026) & (US$ Million)
 Table 122. CGT Global Recent Development
 Table 123. Immortalized Human Cells Market Trends
 Table 124. Immortalized Human Cells Market Drivers
 Table 125. Immortalized Human Cells Market Challenges
 Table 126. Immortalized Human Cells Market Restraints
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources


List of Figures
 Figure 1. Immortalized Human Cells Product Picture
 Figure 2. Global Immortalized Human Cells Market Share by Type: 2025 vs 2032
 Figure 3. Ready-to-use Features
 Figure 4. Customized Features
 Figure 5. Global Immortalized Human Cells Market Share by Application: 2025 vs 2032
 Figure 6. Medical Research
 Figure 7. Vaccine Development
 Figure 8. Gene Therapy
 Figure 9. Other
 Figure 10. Immortalized Human Cells Report Years Considered
 Figure 11. Global Immortalized Human Cells Market Size (US$ Million), Year-over-Year: 2021-2032
 Figure 12. Global Immortalized Human Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Immortalized Human Cells Market Share by Revenue, by Region: 2021 vs 2025
 Figure 14. North America Immortalized Human Cells Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 15. Europe Immortalized Human Cells Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 16. China Immortalized Human Cells Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 17. Japan Immortalized Human Cells Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 18. Global Immortalized Human Cells Market Share by Players in 2025
 Figure 19. Global Top Immortalized Human Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immortalized Human Cells as of 2025)
 Figure 20. The Top 10 and 5 Players Market Share by Immortalized Human Cells Revenue in 2025
 Figure 21. North America Immortalized Human Cells Market Share by Type (2021-2026)
 Figure 22. North America Immortalized Human Cells Market Share by Application (2021-2026)
 Figure 23. Europe Immortalized Human Cells Market Share by Type (2021-2026)
 Figure 24. Europe Immortalized Human Cells Market Share by Application (2021-2026)
 Figure 25. China Immortalized Human Cells Market Share by Type (2021-2026)
 Figure 26. China Immortalized Human Cells Market Share by Application (2021-2026)
 Figure 27. Japan Immortalized Human Cells Market Share by Type (2021-2026)
 Figure 28. Japan Immortalized Human Cells Market Share by Application (2021-2026)
 Figure 29. Ispecimen Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 30. ABO Bio Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 31. AnaBios Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 32. Biomedica Cro Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 33. Bioivt Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 34. Iprocess Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 35. Crown Bioscience Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 36. Biomex Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 37. PrecisionMed Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 38. Cureline Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 39. DX Biosamples Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 40. Audubon Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 41. Precision for Medicine Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 42. Discovery Life Sciences Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 43. ProteoGenex Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 44. CGT Global Revenue Growth Rate in Immortalized Human Cells Business (2021-2026)
 Figure 45. Bottom-up and Top-down Approaches for This Report
 Figure 46. Data Triangulation
 Figure 47. Key Executives Interviewed

Description 

The global Immortalized Human Cells market size was US$ 1577 million in 2025 and is forecast to reach a readjusted size of US$ 3407 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.

The global volume of technical services related to immortalized human cells reached approximately 3.72 million projects in 2024, with an average customer price of $403.15 per project. Immortalized human cells are human cell lines with unlimited proliferative capacity obtained through genetic engineering techniques. Related technical services include cell line establishment, gene editing, functional validation, drug screening, and customized culture. These services provide crucial technology platforms and solutions for drug development, disease modeling, and biomedical research, significantly enhancing research efficiency and reliability.
The technical service market for immortalized human cells is currently in a critical phase of rapid professionalization and standardization. The market's current state is characterized by growing demand for regulatory-compliant standardized cell line establishment, complex gene editing, and high-quality functional validation services, driven by the needs of precision medicine and personalized therapies. Professional CRO companies and large biotechnology firms dominate the market by establishing standardized technology platforms and quality systems. The development trend is clearly directed towards higher throughput and more precise technical services, including the integration of innovative services such as automated screening platforms, multi-omics analysis integration, and AI-assisted cell phenotype analysis. The prevailing market view is that future competition will extend beyond basic technical services to focus more on the capability to provide integrated solutions, data quality and depth of analytical value, and the completeness of technical systems meeting stringent regulatory requirements. Meanwhile, balancing service standardization with personalized needs will become a significant challenge for enterprises.

The global Immortalized Human Cells market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
By Company: 
    Ispecimen
    ABO Bio
    AnaBios
    Biomedica Cro
    Bioivt
    Iprocess
    Crown Bioscience
    Biomex
    PrecisionMed
    Cureline
    DX Biosamples
    Audubon
    Precision for Medicine
    Discovery Life Sciences
    ProteoGenex
    CGT Global

Segment by Type
    Ready-to-use
    Customized

Segment by Application
    Medical Research
    Vaccine Development
    Gene Therapy
    Other

By Region 
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
    North America
    Europe
    China
    Japan

(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Immortalized Human Cells market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets 
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities 
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Immortalized Human Cells value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
undefined
den_biaoTiZhungShi

Related Reports

Global Immortalized Human Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-24

Pages: 108 Pages

Report ld: 6271408

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now